Days Alive and Out of Hospital as an Outcome Measure in Patients Receiving Hyperacute Stroke Intervention.
Joseph DonnellyJae Beom HongLuke BoyleVivien T Y YongWilliam K DiproseJuliette MeyerDouglas CampbellPeter Alan BarberPublished in: Journal of the American Heart Association (2024)
In patients with stroke treated with reperfusion therapies, DAOH-90 shows reasonable comparability to the more established outcome measure of mRS-90. DAOH-90 can be readily obtained from administrative databases and therefore has the potential to be used in large-scale clinical trials and comparative effectiveness studies.
Keyphrases
- atrial fibrillation
- clinical trial
- cerebral ischemia
- randomized controlled trial
- healthcare
- acute myocardial infarction
- emergency department
- subarachnoid hemorrhage
- heart failure
- brain injury
- big data
- acute coronary syndrome
- human health
- blood brain barrier
- risk assessment
- acute ischemic stroke
- case control
- artificial intelligence
- phase ii
- open label
- double blind
- placebo controlled